ALLMedicine™ Hepatorenal Syndrome Center

Mar 3rd, 2021 - The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-1) in many parts of the world and is part of the clinical practice guidelines in Europe. We conducted a phase 3 trial to confirm the efficacy and safety of terlipressin ...

Feb 27th, 2021 - CRRT is often used to support the intra-operative course during liver transplantation ( LT) for patients with HRS. However, the use of intraoperative CRRT (IOCRRT) is not without its problems. Living donor liver transplantation (LDLT) is a planned...

Jan 13th, 2021 - Point-of-Care (POC) transthoracic echocardiography (TTE) is transforming the management of patients with cirrhosis presenting with septic shock, acute kidney injury, hepatorenal syndrome and acute-on-chronic liver failure (ACLF) by correctly asses...

Dec 31st, 2020 - Background/Aims. Hepatorenal syndrome (HRS) is a form of functional renal failure arising in advanced cirrhosis and is characterized by a poor survival rate. Anemia is frequently observed during the clinical course of cirrhosis. Our study aimed to...

Oct 20th, 2020 - Hepatorenal syndrome is a rare entity that is part of the complications of liver cirrhosis in its more severe stages. Without treatment, its mortality rate increases significantly. Terlipressin is considered to be the therapy of choice until the n...

Jul 16th, 2010 - EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.|2010| ,|therapeutic use,diagnosis,etiology,therapy,diagnosis,etiology,therapy,therapeutic use,diagnosis,etiol...

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

Mar 3rd, 2021 - The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-1) in many parts of the world and is part of the clinical practice guidelines in Europe. We conducted a phase 3 trial to confirm the efficacy and safety of terlipressin ...

Feb 27th, 2021 - CRRT is often used to support the intra-operative course during liver transplantation ( LT) for patients with HRS. However, the use of intraoperative CRRT (IOCRRT) is not without its problems. Living donor liver transplantation (LDLT) is a planned...

Jan 13th, 2021 - Point-of-Care (POC) transthoracic echocardiography (TTE) is transforming the management of patients with cirrhosis presenting with septic shock, acute kidney injury, hepatorenal syndrome and acute-on-chronic liver failure (ACLF) by correctly asses...

Dec 31st, 2020 - Background/Aims. Hepatorenal syndrome (HRS) is a form of functional renal failure arising in advanced cirrhosis and is characterized by a poor survival rate. Anemia is frequently observed during the clinical course of cirrhosis. Our study aimed to...

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

Jul 15th, 2020 - The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment of hepatorenal syndrome type 1, a seve...

Jul 15th, 2020 - The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment of hepatorenal syndrome type 1, a seve...

Jul 5th, 2020 - In this case, the patient's postprocedural course was characterized initially by worsening liver failure, elevated intra-abdominal pressures, and confusion. He eventually progressed to frank encephalopathy, hepatorenal syndrome, and pneumonia. Ult...

Jun 11th, 2020 - Takeaway Terlipressin is the most commonly prescribed vasoconstrictor for hospitalised patients with hepatorenal syndrome-acute kidney injury (HRS-AKI) in the UK, consistent with current guidelines. Initiation of terlipressin in patients with less...